SCHEMBL8068858

SCHEMBL8068858

Clc1cccc2nc(-c3cccs3)nc(Cl)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.43
GBA1 P04062 7/20 0.42
MAPT P10636 7/20 0.42
KDM4E B2RXH2 6/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
XPO1 O14980 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA1 P30542 1/20 0.41
ALDH1A1 P00352 5/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
HPGD P15428 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.40
POLB P06746 1/20 0.40
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8070444 0.85 KDM4E (0.43) PDE5AGBA1MAPTKDM4ENPC1
SCHEMBL8059496 0.85 PDE5A (0.42) PDE5AGBA1MAPTKDM4ENPC1
SCHEMBL8071071 0.85 MAPT (0.45) PDE5AGBA1MAPTKDM4ENPC1
SCHEMBL8070655 0.81 XPO1 (0.58) GBA1MAPTKDM4ENPC1RAB9A
SCHEMBL38652109 0.78 PDE5A (0.60) PDE5AGBA1MAPTKDM4EADORA2A
SCHEMBL7285850 0.78 PDE5A (0.60) PDE5AGBA1MAPTKDM4EADORA2A
SCHEMBL14095493 0.76 ADORA2A (0.59) PDE5AGBA1MAPTKDM4EADORA2A
SCHEMBL19148655 0.71 KDM4E (0.58) PDE5AMAPTKDM4ENPC1RAB9A
SCHEMBL5321138 0.71 FLT3 (0.64) MAPTKDM4ENPC1RAB9AALDH1A1
SCHEMBL8075316 0.71 ELANE (0.62) MAPTKDM4ENPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150372-A IMMUNOINFLAMMATORY AND AUTOIMMUNE DISEASES; BLOCKING INTRACELLULAR SIGNAL TRANSDUCTION AND ACTIVATION OF TRANSCRIPTION FACTORS; KINASE INHIBITORS; ANTIARTHRITIC, ISCHEMIC AGENTS, MULTIPLE SCLEROSIS, TRANSPLANT REJECTION SIGNAL PHARMACEUTICALS, INC. (US) 2000-11-21 US disclosed
US-5939421-A TREATMENT OF IMMUNOINFLAMMATORY AND AUTOIMMUNE DISEASES SUCH AS RHEUMATOID ARTHRITIS, TRANSPLANT REJECTION; INHIBIT KINASE(S) THAT REGULATE ACTIVATION OF TRANSCRIPTION FACTORS TO PREVENT PRODUCTION OF INFLAMMATORY PROTEINS SIGNAL PHARMACEUTICALS, INC. (US) 1999-08-17 US disclosed
WO-1999001441-A1 QUINAZOLINE ANALOGS AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1999-01-14 WO disclosed